By Raziel Therapeutics
RZL-012, our novel synthetic small molecule (NCE) kills fat cells when injected into subcutaneous fat. It is the first and only injectable drug shown to significantly and sustainably shrink the size of Lipomas in Dercum’s Disease, reduce the volume of abdominal fat (body contouring) and submental fullness (double chin). In vitro studies show that RZL-012 reduces the ability of fat cells to accumulate or store fat.
Read more here.